A rare case of multifocal inflammatory pseudotumor involving the orbit, skull base, and cauda equina was documented in a patient with HIV infection, resulting in progressive visual loss and complex diagnostic and management challenges.
Managing rare, inflammatory central nervous system manifestations in immunocompromised patients requires close collaboration across specialties. Understanding how systemic conditions interact with atypical tissue growths helps clinicians navigate similar diagnostic puzzles.
In Plain English: The Clinical Takeaway
- What it is: An inflammatory pseudotumor is a non-cancerous mass of immune cells and scar tissue that mimics a tumor, appearing here in multiple locations including the eye socket, skull base, and spinal cord region.
- The HIV Context: Patients with human immunodeficiency virus (HIV) can experience unique immune-mediated complications that require careful differentiation from opportunistic infections or malignancies.
- Clinical Impact: Because these masses can press on critical neural structures, patients may experience severe symptoms such as progressive vision loss, demanding prompt evaluation and tailored anti-inflammatory or immunomodulatory therapy.
Clinical Presentation and Diagnostic Path
The case report details the clinical journey of a patient presenting with progressive visual loss alongside complex neurological signs. Inflammatory pseudotumors are notoriously difficult to diagnose because their radiographic appearance closely resembles malignant neoplasms or infectious granulomas. In this patient, the involvement spanned the orbit, the skull base, and the cauda equina—the bundle of nerves at the base of the spinal cord.
Histopathological evaluation remains the gold standard for confirming an inflammatory pseudotumor, ruling out lymphoma, metastasis, or chronic fungal and bacterial infections. In the context of HIV infection, maintaining a broad differential diagnosis is critical, as immunosuppression alters both the presentation and the progression of inflammatory and infectious disorders.
Mechanism of Action and Anatomical Impact
An inflammatory pseudotumor is characterized by a localized proliferation of lymphocytes, plasma cells, and fibroblasts, driven by an aberrant immune response. When these lesions develop within the restricted space of the orbit, they compress the optic nerve, causing visual impairment. Extension into the skull base and the cauda equina introduces additional neurological deficits depending on the specific nerve roots or brain structures involved.
In HIV-positive individuals, immune dysregulation can prime tissues for exaggerated inflammatory responses following minor triggers or opportunistic exposures. Corticosteroids and other immunomodulating agents are typically employed to reduce the mass effect by dampening this localized cellular proliferation.
| Anatomical Site | Observed Manifestation | Primary Clinical Consequence |
|---|---|---|
| Orbit | Multifocal inflammatory pseudotumor | Progressive visual loss, optic nerve compression |
| Skull Base | Infiltrative inflammatory mass | Potential cranial neuropathy, local pain |
| Cauda Equina | Multifocal spinal involvement | Radicular symptoms, lower spinal nerve compression |
Contraindications & When to Consult a Doctor
Corticosteroids and immunosuppressive therapies, which form the cornerstone of inflammatory pseudotumor management, are contraindicated in patients with active, uncontrolled opportunistic infections until antimicrobial coverage is established. Clinicians must weigh the risk of exacerbating underlying infections in HIV patients against the urgent need to preserve neurological function.
Patients experiencing rapid vision changes, new-onset focal neurological deficits, persistent headaches, or unexplained back pain associated with neurological symptoms should seek immediate medical evaluation. Timely neuroimaging and multidisciplinary assessment by neurology, ophthalmology, and infectious disease specialists are vital to prevent permanent nerve damage.
Conclusion
This case highlights the intricate interplay between HIV infection and rare, multi-site inflammatory disorders. As clinicians encounter increasingly complex presentations, comprehensive diagnostic workups and individualized treatment regimens remain essential for optimizing patient outcomes.
